Short report: interferon-alpha decreases 14C-aminopyrine breath test values in patients with chronic hepatitis C

Aliment Pharmacol Ther. 1994 Jun;8(3):353-5. doi: 10.1111/j.1365-2036.1994.tb00301.x.

Abstract

Objective: To investigate the effect of interferon-alpha on cytochrome P-450 dependent microsomal function.

Methods: The 14C-aminopyrine breath test was performed before, during and after a standard dose of interferon-alpha (3,000,000 units three times per week) was administered for at least six months (nine patients with chronic hepatitis C).

Results: Mean aminopyrine breath test values obtained during therapy were significantly lower than either pre- or post-treatment, the degree of reduction varying widely between individuals. Pre- and post-treatment aminopyrine breath test values did not differ significantly.

Conclusion: Interferon therapy is associated with a significant and transient inhibition of cytochrome P-450 activity, which should be taken into account when prescribing concurrent therapy with drugs metabolized by this pathway.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Aminopyrine
  • Aminopyrine N-Demethylase / metabolism
  • Breath Tests
  • Chronic Disease
  • Cytochrome P-450 Enzyme Inhibitors
  • Cytochrome P-450 Enzyme System / metabolism*
  • Drug Administration Schedule
  • Female
  • Hepatitis C / therapy*
  • Humans
  • Interferon-alpha / administration & dosage*
  • Male
  • Middle Aged

Substances

  • Cytochrome P-450 Enzyme Inhibitors
  • Interferon-alpha
  • Aminopyrine
  • Cytochrome P-450 Enzyme System
  • Aminopyrine N-Demethylase